Author: Zhu, Shicong; Fu, Yang; Zhu, Bo; Zhang, Bicheng; Wang, Jun
Title: Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational Investigation Cord-id: ykmz8p4j Document date: 2020_9_11
ID: ykmz8p4j
Snippet: Immune checkpoint inhibitors (ICIs) have been applied to clinical practice and achieved significant therapeutic benefit in a variety of human malignancies. These drugs not only enhance the body’s antitumor immune response but also produce side effects called immune-related adverse events (irAEs). Although checkpoint inhibitor pneumonitis (CIP) has a low clinical incidence, it is likely to cause the delay or termination of immunotherapy and treatment-related death in some severe cases. An incre
Document: Immune checkpoint inhibitors (ICIs) have been applied to clinical practice and achieved significant therapeutic benefit in a variety of human malignancies. These drugs not only enhance the body’s antitumor immune response but also produce side effects called immune-related adverse events (irAEs). Although checkpoint inhibitor pneumonitis (CIP) has a low clinical incidence, it is likely to cause the delay or termination of immunotherapy and treatment-related death in some severe cases. An increasing number of CIP cases have been reported since 2015, which are attributed to the augmentation of approvals and uses of ICIs, but a comprehensive understanding of CIP is still lacking. This review focuses on the epidemiology, clinical characteristics, treatment strategies, and underlying mechanisms of CIP to strengthen the recognition of pulmonary toxicity among clinicians and researchers.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and lung biopsy tissue: 1
- acute ards respiratory distress syndrome and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute ards respiratory distress syndrome and lung capacity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute ards respiratory distress syndrome and lung consolidation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- adenocarcinoma histology and lung cancer: 1, 2, 3, 4, 5
- adenocarcinoma tumor and lung biopsy: 1
- adenocarcinoma tumor and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- adenocarcinoma tumor and lung capacity: 1
- lobular septum and lung consolidation: 1
Co phrase search for related documents, hyperlinks ordered by date